Has the Pandemic Changed Type 1 Diabetes Care for Good?

MONDAY, Oct. 5, 2020 (HealthDay News) — When the COVID-19 pandemic began, many doctors started providing care via telemedicine. Now, a new survey of people with type 1 diabetes suggests many like remote care and hope it continues in the future.

Among the survey respondents who had a telemedicine visit during the pandemic, 86% found the remote appointments useful, and 75% said they planned on having remote appointments in the future, according to the Swiss study.

“COVID really forced the issue of access to telemedicine. There were a lot of restrictions that made it difficult to access telemedicine in the past that were lifted with COVID. But will they remain available?” said Dr. Mary Pat Gallagher, director of the Pediatric Diabetes Center at NYU Langone Health in New York City.

“It’s quite clear from my clinical experience that people really like this and would prefer it. I would like this to continue to be an option for our families,” added Gallagher, who was not involved in the current research.

People with type 1 diabetes need to take multiple daily insulin shots or receive insulin via an insulin pump because they don’t make enough insulin on their own. Insulin is a hormone that ushers sugar from foods into the body’s cells for fuel.

More here –> here

Print Friendly, PDF & Email